Technology Center
Aperbio's proprietary nucleic acid detection platform integrates international-leading Digital PCR and Real-time PCR technologies — enabling sub-single-molecule precision across clinical diagnostics and life sciences research.
Dual-Platform Strategy
Aperbio has developed two complementary nucleic acid detection platforms that address the full spectrum of molecular biology needs — from sub-femtomolar absolute quantification to rapid high-throughput clinical screening.
Digital PCR (dPCR)
Absolute quantification without standard curves. Partition-based amplification achieves single-molecule sensitivity with >99.9% accuracy — ideal for rare mutation detection, CNV analysis, and reference standard verification.
- Single-molecule sensitivity
- No standard curve required
- Resistant to PCR inhibitors
- Multiplex detection capability
Real-time PCR (qPCR)
Optical waveguide-based fluorescence detection across 6 channels with an 11-decade dynamic range. Clinical-grade systems deliver NMPA-registered performance for pathogen detection, oncology screening, and pharmacogenomics.
- 6-channel multiplex detection
- 11-decade dynamic range
- NMPA-registered platforms
- Ultra-fast run times (30–45 min)
Digital PCR Platform
Aperbio's Aegaeon Crystal Digital PCR series sets a new standard for absolute nucleic acid quantification. Crystal microfluidic partitioning ensures precise droplet uniformity for reproducible results across every run.
Aegaeon Crystal dPCR XW+
High-throughput digital PCR system with crystal microfluidic partitioning. 96-channel multiplex, automated droplet generation, 3-colour simultaneous detection.
Aegaeon Crystal Digital PCR System
Compact research-grade dPCR for laboratories requiring absolute quantification in gene expression, CNV analysis, rare allele detection, and liquid biopsy workflows.
qMate Mini Nucleic Acid Extraction System
Fully automated nucleic acid extraction for blood, swabs, FFPE tissue and other biological samples. Integrated with Aperbio's dPCR and qPCR workflows for contamination-free sample handling.
- Processes 1–8 samples per run
- Compatible with all Aperbio PCR platforms
- Magnetic bead extraction — no centrifugation
Real-time PCR Platform
Our Pangaea and Kingwell real-time PCR systems bring clinical-grade performance to both diagnostic labs and research environments. NMPA-registered for clinical use in China.
Pangaea Fast Real-time PCR
NMPA-registered clinical diagnostic platform with optical waveguide technology. 6-channel detection, 11-decade dynamic range, 45-minute run times.
Pangaea Super8 Pro Dx
Ultra-fast PCR system designed for high-throughput clinical environments. Completes full diagnostic runs in approximately 30 minutes with ±0.05°C temperature accuracy.
Kingwell DX Automated Cycler
Research and clinical thermal cycler with gold-plated block, ±0.1°C uniformity, and 7°C/s ramp rate. Dual-block and mixed-protocol modes for maximum flexibility.
Where Our Technology Delivers
Aperbio's nucleic acid detection platforms power both clinical diagnostics workflows and life sciences research applications.
🏥 Medical Diagnosis
Clinical-validated platforms supporting precision diagnostics across oncology, hematology, and infectious disease.
- Pathogen Detection — TB, malaria, influenza, HFMD
- Genetic Disease Diagnosis — hereditary mutation panels
- Cancer Diagnosis & Monitoring — MRD, liquid biopsy, cfDNA
- Personalized Medicine — companion diagnostics & pharmacogenomics
🔬 Life Sciences Research
Research-grade platforms for genomics, molecular biology, and discovery sciences from academia to pharmaceutical R&D.
- Gene Cloning & Expression Analysis
- Gene Mutation Detection & CNV
- Forensic Science applications
- Evolution & Phylogenetic Studies
- Environmental Monitoring
- Agricultural Sciences (GMO detection)
Ready to Experience Precision?
Contact our team for a product demonstration, quotation, or technical consultation. Our application scientists are ready to help you find the right platform for your workflow.